Cargando…
ETIOPATHOGENIC, EPIDEMIOLOGIC AND CLINICAL-THERAPEUTIC COMPARISON OF NON-HODGKIN’S LYMPHOMA AND KAPOSI’S SARCOMA
BACKGROUND: Non-Hodgkin’s lymphomas (NHL) are primary neoplasms derived from lymphocytes, and Kaposi’s sarcoma (SK) is a multicentric disease of viral etiology and is associated with HIV. AIM: To study the etiopathogenesis and clinical characteristics of NHL and KS, describing their mutual factors....
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Colégio Brasileiro de Cirurgia Digestiva
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682145/ https://www.ncbi.nlm.nih.gov/pubmed/33237165 http://dx.doi.org/10.1590/0102-672020200002e1521 |
_version_ | 1783612651041980416 |
---|---|
author | PETROIANU, Andy ALBERTI, Luiz Ronaldo ORSI, Vanessa Lacerda VIANA, Flávia Costa Teixeira MOURA, Carolina Braga |
author_facet | PETROIANU, Andy ALBERTI, Luiz Ronaldo ORSI, Vanessa Lacerda VIANA, Flávia Costa Teixeira MOURA, Carolina Braga |
author_sort | PETROIANU, Andy |
collection | PubMed |
description | BACKGROUND: Non-Hodgkin’s lymphomas (NHL) are primary neoplasms derived from lymphocytes, and Kaposi’s sarcoma (SK) is a multicentric disease of viral etiology and is associated with HIV. AIM: To study the etiopathogenesis and clinical characteristics of NHL and KS, describing their mutual factors. METHODS: This retrospective investigation was performed on 101 medical charts. The patients were studied according to their age, gender, and HIV-positivity, following the PRISMA guidelines. The characteristics of the tumors and comorbidities were analyzed according to their age and lymphatic metastasis. RESULTS: The mean age of the patients ranged between 15-87 years for NHL and between 25-54 for KS, but the age of patients with NHL associated with HIV did not surpass 34 years. The ratio male: female was 1,8:1 for NHL, but only men presented KS. HIV-positivity was found in five patients with NHL and in 14 with KS. The stages of NHL were: I (21%), II (18,4%), III (26,3%), and IV (34,2%), but KS were found only at III (40%) and IV (60%) stages. The lymphatic metastases were positive in 62 patients NHL and in four with KS. HIV-positivity occurred in 60% of patients with NHL and in 50% with KS. CONCLUSION: The HIV seropositivity was revealed for most of patients during the NHL and SK propaedeutic and none of them present clinical manifestations of AIDS. NHL associated with HIV was found only in young patients. NHL and KS patients have similar epidemiological, clinical, and therapeutic characteristics. |
format | Online Article Text |
id | pubmed-7682145 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Colégio Brasileiro de Cirurgia Digestiva |
record_format | MEDLINE/PubMed |
spelling | pubmed-76821452020-11-25 ETIOPATHOGENIC, EPIDEMIOLOGIC AND CLINICAL-THERAPEUTIC COMPARISON OF NON-HODGKIN’S LYMPHOMA AND KAPOSI’S SARCOMA PETROIANU, Andy ALBERTI, Luiz Ronaldo ORSI, Vanessa Lacerda VIANA, Flávia Costa Teixeira MOURA, Carolina Braga Arq Bras Cir Dig Original Article BACKGROUND: Non-Hodgkin’s lymphomas (NHL) are primary neoplasms derived from lymphocytes, and Kaposi’s sarcoma (SK) is a multicentric disease of viral etiology and is associated with HIV. AIM: To study the etiopathogenesis and clinical characteristics of NHL and KS, describing their mutual factors. METHODS: This retrospective investigation was performed on 101 medical charts. The patients were studied according to their age, gender, and HIV-positivity, following the PRISMA guidelines. The characteristics of the tumors and comorbidities were analyzed according to their age and lymphatic metastasis. RESULTS: The mean age of the patients ranged between 15-87 years for NHL and between 25-54 for KS, but the age of patients with NHL associated with HIV did not surpass 34 years. The ratio male: female was 1,8:1 for NHL, but only men presented KS. HIV-positivity was found in five patients with NHL and in 14 with KS. The stages of NHL were: I (21%), II (18,4%), III (26,3%), and IV (34,2%), but KS were found only at III (40%) and IV (60%) stages. The lymphatic metastases were positive in 62 patients NHL and in four with KS. HIV-positivity occurred in 60% of patients with NHL and in 50% with KS. CONCLUSION: The HIV seropositivity was revealed for most of patients during the NHL and SK propaedeutic and none of them present clinical manifestations of AIDS. NHL associated with HIV was found only in young patients. NHL and KS patients have similar epidemiological, clinical, and therapeutic characteristics. Colégio Brasileiro de Cirurgia Digestiva 2020-11-20 /pmc/articles/PMC7682145/ /pubmed/33237165 http://dx.doi.org/10.1590/0102-672020200002e1521 Text en https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License |
spellingShingle | Original Article PETROIANU, Andy ALBERTI, Luiz Ronaldo ORSI, Vanessa Lacerda VIANA, Flávia Costa Teixeira MOURA, Carolina Braga ETIOPATHOGENIC, EPIDEMIOLOGIC AND CLINICAL-THERAPEUTIC COMPARISON OF NON-HODGKIN’S LYMPHOMA AND KAPOSI’S SARCOMA |
title | ETIOPATHOGENIC, EPIDEMIOLOGIC AND CLINICAL-THERAPEUTIC COMPARISON OF
NON-HODGKIN’S LYMPHOMA AND KAPOSI’S SARCOMA |
title_full | ETIOPATHOGENIC, EPIDEMIOLOGIC AND CLINICAL-THERAPEUTIC COMPARISON OF
NON-HODGKIN’S LYMPHOMA AND KAPOSI’S SARCOMA |
title_fullStr | ETIOPATHOGENIC, EPIDEMIOLOGIC AND CLINICAL-THERAPEUTIC COMPARISON OF
NON-HODGKIN’S LYMPHOMA AND KAPOSI’S SARCOMA |
title_full_unstemmed | ETIOPATHOGENIC, EPIDEMIOLOGIC AND CLINICAL-THERAPEUTIC COMPARISON OF
NON-HODGKIN’S LYMPHOMA AND KAPOSI’S SARCOMA |
title_short | ETIOPATHOGENIC, EPIDEMIOLOGIC AND CLINICAL-THERAPEUTIC COMPARISON OF
NON-HODGKIN’S LYMPHOMA AND KAPOSI’S SARCOMA |
title_sort | etiopathogenic, epidemiologic and clinical-therapeutic comparison of
non-hodgkin’s lymphoma and kaposi’s sarcoma |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682145/ https://www.ncbi.nlm.nih.gov/pubmed/33237165 http://dx.doi.org/10.1590/0102-672020200002e1521 |
work_keys_str_mv | AT petroianuandy etiopathogenicepidemiologicandclinicaltherapeuticcomparisonofnonhodgkinslymphomaandkaposissarcoma AT albertiluizronaldo etiopathogenicepidemiologicandclinicaltherapeuticcomparisonofnonhodgkinslymphomaandkaposissarcoma AT orsivanessalacerda etiopathogenicepidemiologicandclinicaltherapeuticcomparisonofnonhodgkinslymphomaandkaposissarcoma AT vianaflaviacostateixeira etiopathogenicepidemiologicandclinicaltherapeuticcomparisonofnonhodgkinslymphomaandkaposissarcoma AT mouracarolinabraga etiopathogenicepidemiologicandclinicaltherapeuticcomparisonofnonhodgkinslymphomaandkaposissarcoma |